Skip to Content
Author: The BCW

Leave a Comment

Regeneron Gets FDA Approval for EYLEA’s Pediatric Treatment

In another breakthrough for BCW Member Regeneron Pharmaceuticals, the U.S. Food and Drug Administration (FDA) has approved the company’s EYLEA® (aflibercept) Injection to treat preterm infants with retinopathy of prematurity (ROP). Following this first pediatric approval, EYLEA is now indicated to treat five retinal conditions caused by ocular angiogenesis.

“Retinopathy of prematurity is a leading cause of childhood blindness worldwide. Until now, the only FDA-approved treatment in common use was laser photocoagulation, a complex and lengthy procedure that permanently ablates retina tissue and is stressful not only for infant patients but also the family navigating a delicate time after a preterm birth,” said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron, and a principal inventor of EYLEA. “For the first time, physicians will now have an FDA approved medication in EYLEA to treat this heartbreaking disease in these smallest of patients. We thank the investigators and the many families who participated in the clinical trials.”

Each year in the U.S., between 1,100 to 1,500 infants develop ROP that is severe enough to require medical treatment. This rare eye disease often impacts infants who are born before 31 weeks of pregnancy have been completed or who weigh less than 3.3 lbs pounds at birth. “Regeneron’s trials investigating EYLEA in retinopathy of prematurity have advanced our understanding of how to treat this disease and provided a needed evidence-based treatment option to potentially help preterm infants preserve their vision,” said Jeff Todd, Chief Executive Officer of Prevent Blindness.

EYLEA is being jointly developed by Regeneron and Bayer.

Similar News Items

The Business Council of Westchester (BCW) hosted its exclusive VIP Member Summer Reception on Tuesday at the Trump National Golf Club Westchester in Briarcliff Manor. The elegant gathering brought together approximately 125 guests for an evening of networking and connection amid the stunning Trump National Golf Club Westchester. Attendees enjoyed the club’s renowned five-star private […]

Read Article

BCW Member Community Housing Innovations (CHI), a nonprofit dedicated to housing solutions, will be offering practical and financial assistance to first-time home buyers at its 2025 Homeownership Expo to be held tomorrow at the Sonesta Hotel in White Plains from 11 am to 3 pm. Prospective homeowners or those who already own a home but […]

Read Article

In a historic milestone that was 15 years in the making, officials from Yonkers, New York State, Westchester County, U.S. Department of Housing and Urban Development and the NYS Homes and Community Renewal on Wednesday joined with the Mulford Corporation, The Community Builders (TCB) and BCW Member Yonkers Housing Authority to celebrate the groundbreaking for […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

JOIN NOW!
The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top